Gufic Biosciences Limited (BOM:509079)

Gufic Biosciences Revenue

Gufic Biosciences had revenue of 2.31B INR in the quarter ending December 31, 2025, with 11.37% growth. This brings the company's revenue in the last twelve months to 8.97B, up 10.80% year-over-year. In the fiscal year ending March 31, 2025, Gufic Biosciences had annual revenue of 8.20B with 1.63% growth.

• Revenue (ttm): 8.97B
• Revenue Growth: +10.80%
• P/S Ratio: 3.55
• Revenue / Employee: 6.05M
• Employees: 1,484
• Market Cap: 31.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	8.20B	131.40M	1.63%
Mar 31, 2024	8.07B	1.16B	16.80%
Mar 31, 2023	6.91B	-885.35M	-11.36%
Mar 31, 2022	7.79B	2.91B	59.76%
Mar 31, 2021	4.88B	1.09B	28.74%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 24, 2026

Data Sources Report a data error